NEWS

Vancouver, British Columbia – Chesapeake Gold Corp. (TSXV: CKG) (OTCQX: CHPGF) (“Chesapeake” or the “Company”) is pleased to provide a progress update on its proprietary heap oxidation technology (“Technology”) on its Metates project, located in Durango, Mexico.  Jean-Paul Tsotsos, Chief Executive Officer, commented, “The first results from the third phase of Metates’ metallurgical testing highlight several significant advances through our variability program, including the ability to maintain and improve precious metals recoveries while reducing oxidation times.  The improvements are expected to provide several cost-economic benefits and the opportunity to further enhance production while lowering working capital and costs.  In addition, the preliminary High Pressure Grinding Roll (“HPGR”) testwork underway offers

VANCOUVER, B.C. – Chesapeake Gold Corp. (TSXV:CKG, OTCQX:CHPGF) (“Chesapeake” or the “Company”) announces the grant of stock options under its Stock Option Plan to purchase an aggregate of 227,000 common shares of the Company at an exercise price of C$2.95 per share for a five‑year term expiring July 31, 2031. The stock options were granted to officers of the Company. The options will vest and be exercisable on the basis of 25% annually, commencing July 31, 2027, the first anniversary of the date of the grant. About Chesapeake Chesapeake Gold Corp’s flagship asset is the Metates Project (“Metates”) located in Durango State, Mexico. Metates hosts one of the largest undeveloped gold-silver

VANCOUVER, B.C. – Chesapeake Gold Corp. (TSXV:CKG, OTCQX:CHPGF) (“Chesapeake” or the “Company”) announces the grant of stock options under its Stock Option Plan to purchase an aggregate of 2,200,000 common shares of the Company at an exercise price of C$3.40 per share for a five‑year term expiring May 7, 2031. The stock options were granted to directors and a consultant of the Company. The options will vest and be exercisable on the basis of 25% annually, commencing May 7, 2027, the first anniversary of the date of the grant. For Further Information: For more information on Chesapeake, its Metates and Lucy Projects or proprietary oxidative leach technology, please visit our website

VANCOUVER, B.C. – Chesapeake Gold Corp. (TSXV: CKG) (OTCQX: CHPGF) (“Chesapeake” or the “Company”) is pleased to announce that it has received a U.S. Patent (U.S. Patent Number 12,595,529) for its proprietary method of enhanced metal recovery from sulphide ores.  The patent, awarded by the U.S. Patent and Trademark Office, represents a significant achievement in Chesapeake’s heap oxidation technology (“Technology”).  Jean-Paul Tsotsos, Chief Executive Officer of Chesapeake, stated, “The U.S. patent is an important milestone for Chesapeake. The patent protects Chesapeake’s Technology and reinforces the strength of our intellectual property.  The patent supports our corporate strategy to build shareholder value from the Technology, unlocking economic value from refractory sulphide gold

VANCOUVER, B.C. – Chesapeake Gold Corp. (TSXV:CKG, OTCQX:CHPGF) (“Chesapeake” or the “Company”) is pleased to announce that it has been named to the TSX Venture 50 list of top performing companies on the TSX Venture Exchange (“TSXV”), based on an outstanding 388% share price appreciation and 415% market capitalization growth in 2025. The 2026 TSX Venture 50 showcases the top 51 of over 1,600 TSXV issuers. Eligible listed issuers are ranked based on three equally weighted criteria of one-year share price appreciation, market capitalization growth, and Canadian consolidated trading value as of December 31, 2025.  The companies on the list delivered an average share price appreciation of 431% to investors

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, British Columbia – January 27, 2026 – Chesapeake Gold Corp. (TSXV:CKG) (“Chesapeake” or the “Company”) is pleased to announce that it has closed its previously announced bought deal public offering (the “Brokered Offering”) of 4,107,225 units of the Company (the “Units”) at a price of $4.20 per Unit (the “Issue Price”) for aggregate gross proceeds of $17,250,345, which includes the full exercise of the over‑allotment option. Each Unit consists of one common share of the Company (each, a “Common Share”) and one-half of one Common Share purchase warrant (each full warrant, a “Warrant”). Each